Lei Stanley Qi

The native form of this personal name is Qi Lei. This article uses Western name order when mentioning individuals.

Lei "Stanley" Qi (Chinese: 亓磊; pinyin: Qí Lěi) is an associate professor in the department of bioengineering, and the department of chemical and systems biology at Stanford University. Qi led the development of the first catalytically dead Cas9 lacking endonuclease activity (dCas9), which is the basis for CRISPR interference (CRISPRi). His laboratory subsequently developed CRISPR-Genome Organization (CRISPR-GO) based on dCas9^[1] and CRISPR-Transcriptome Organization (CRISPR-TO) based on dCas13.^[2]

Lei Stanley Qi
Born	Qi Lei (亓磊) Shandong, China
Nationality	Chinese
Alma mater	Tsinghua University (B.A.) UC Berkeley (Ph.D.)
Known for	CRISPRi, dCas9，CRISPR imaging，CRISPR-GO
Awards	Sloan Research Fellowship (2017) Pew Scholar (2016) NIH Directors Early Independence Award (2013)
Scientific career
Fields	Genome engineering, Synthetic Biology
Institutions	Stanford, Chemical and Systems Biology
Academic advisors	Adam Arkin, Jennifer Doudna
Website	med.stanford.edu/qilab.html qi.ucsf.edu

Qi is a co-inventor of the University of California patent on the CRISPR gene-editing technology.

Early life and education

Qi obtained his B.S. in physics and math from Tsinghua University,^[3] China, Master in physics from UC Berkeley, and PhD in bioengineering from UC Berkeley.^[4] During his PhD work at Berkeley, he studied synthetic biology with Adam Arkin, and was the first to explore engineering the CRISPR for targeted gene editing and gene regulation with Jennifer Doudna.^[5] After PhD, he performed independent research work as a faculty fellow at UCSF.^[6] He joined the Stanford faculty in 2014.^{[7] [8] [9] [10] [11] [12] [13]}

Award

Qi has won awards, including NIH Director's Early Independence Award,^[14] Pew Biomedical Scholar,^[15] and Alfred. P. Sloan Fellowship.^[16]